Honest Company, Inc. HNST
We take great care to ensure that the data presented and summarized in this overview for Honest Company, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HNST
View all-
Institutional Venture Management Xiii, LLC Menlo Park, CA10.5MShares$49.2 Million24.36% of portfolio
-
Portolan Capital Management, LLC Boston, MA5.36MShares$25.2 Million2.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.15MShares$24.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.98MShares$23.4 Million0.0% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL3.42MShares$16.1 Million3.62% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.55MShares$12 Million0.27% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.4MShares$11.3 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.37MShares$11.1 Million0.03% of portfolio
-
Acadian Asset Management LLC Boston, MA2.2MShares$10.3 Million0.04% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL2.05MShares$9.62 Million0.0% of portfolio
Latest Institutional Activity in HNST
Top Purchases
Top Sells
About HNST
The Honest Company, Inc. manufactures and sells diapers and wipes, skin and personal care, and household and wellness products. The company also offers baby clothing and nursery bedding products. It sells its products through digital and retail sales channels, such as its website and third-party ecommerce sites, as well as brick and mortar retailers. The company was incorporated in 2012 and is headquartered in Los Angeles, California.
Insider Transactions at HNST
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 16
2025
|
Etienne Von Kunssberg SVP, Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
115,122
+50.0%
|
-
|
Mar 12
2025
|
Stephen Winchell Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
20,000
-4.43%
|
$80,000
$4.98 P/Share
|
Mar 11
2025
|
Jonathan Mayle SVP, Customer Sales |
SELL
Open market or private sale
|
Direct |
37,481
-10.86%
|
$149,924
$4.87 P/Share
|
Mar 07
2025
|
David Loretta Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
43,211
-4.5%
|
$172,844
$4.91 P/Share
|
Mar 07
2025
|
Stephen Winchell Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
23,628
-4.97%
|
$94,512
$4.91 P/Share
|
Mar 07
2025
|
Dorria L. Ball Chief People Officer |
SELL
Open market or private sale
|
Direct |
21,274
-7.13%
|
$85,096
$4.91 P/Share
|
Mar 07
2025
|
Brendan Sheehey General Counsel |
SELL
Open market or private sale
|
Direct |
24,873
-4.03%
|
$99,492
$4.91 P/Share
|
Mar 07
2025
|
Carla Vernon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
193,078
-5.69%
|
$772,312
$4.91 P/Share
|
Mar 07
2025
|
Thomas Sternweis SVP, Enterprise Dev. & Strat. |
SELL
Open market or private sale
|
Direct |
17,758
-5.57%
|
$71,032
$4.91 P/Share
|
Mar 07
2025
|
Jonathan Mayle SVP, Customer Sales |
SELL
Open market or private sale
|
Direct |
14,665
-4.07%
|
$58,660
$4.91 P/Share
|
Mar 07
2025
|
Katherine Barton Chief Growth Officer |
SELL
Open market or private sale
|
Direct |
31,234
-3.17%
|
$124,936
$4.91 P/Share
|
Feb 27
2025
|
Thomas Sternweis SVP, Enterprise Dev. & Strat. |
BUY
Grant, award, or other acquisition
|
Direct |
84,713
+20.99%
|
-
|
Feb 27
2025
|
Dorria L. Ball Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
89,600
+23.1%
|
-
|
Feb 27
2025
|
Stephen Winchell Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
92,859
+16.34%
|
-
|
Feb 27
2025
|
Jonathan Mayle SVP, Customer Sales |
BUY
Grant, award, or other acquisition
|
Direct |
84,713
+19.05%
|
-
|
Feb 27
2025
|
Brendan Sheehey General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
92,859
+13.07%
|
-
|
Feb 27
2025
|
Carla Vernon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
627,206
+15.61%
|
-
|
Feb 27
2025
|
Katherine Barton Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
92,859
+8.61%
|
-
|
Jan 01
2025
|
Alissa Hsu Lynch Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,348
+3.83%
|
$65,436
$7.49 P/Share
|
Jan 01
2025
|
Andrea Turner Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,682
+4.41%
|
$67,774
$7.49 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 1.8M shares |
---|---|
Exercise of conversion of derivative security | 680K shares |
Open market or private sale | 4.8M shares |
---|